Oscar Health Inc. (NYSE: OSCR) reported Q3 EPS of ($0.22), $0.05 worse than the analyst estimate of ($0.17). Revenue for the quarter came in at $2.4 billion versus the consensus estimate of $2.33 billion.

For earnings history and earnings-related data on Oscar Health Inc. (OSCR) click here.